BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21888876)

  • 1. A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.
    Zhao H; Lin W; Kumthip K; Cheng D; Fusco DN; Hofmann O; Jilg N; Tai AW; Goto K; Zhang L; Hide W; Jang JY; Peng LF; Chung RT
    J Hepatol; 2012 Feb; 56(2):326-33. PubMed ID: 21888876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.
    Lin W; Zhu C; Hong J; Zhao L; Jilg N; Fusco DN; Schaefer EA; Brisac C; Liu X; Peng LF; Xu Q; Chung RT
    J Hepatol; 2015 May; 62(5):1024-32. PubMed ID: 25481564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
    Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
    J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.
    Jiang D; Guo H; Xu C; Chang J; Gu B; Wang L; Block TM; Guo JT
    J Virol; 2008 Feb; 82(4):1665-78. PubMed ID: 18077728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro.
    Kuga C; Enomoto H; Aizawa N; Takashima T; Ikeda N; Ishii A; Sakai Y; Iwata Y; Tanaka H; Saito M; Iijma H; Nishiguchi S
    Biochem Biophys Res Commun; 2014 Nov; 454(3):453-8. PubMed ID: 25450683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
    Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
    Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication.
    Fusco DN; Brisac C; John SP; Huang YW; Chin CR; Xie T; Zhao H; Jilg N; Zhang L; Chevaliez S; Wambua D; Lin W; Peng L; Chung RT; Brass AL
    Gastroenterology; 2013 Jun; 144(7):1438-49, 1449.e1-9. PubMed ID: 23462180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha interferon on the hepatitis C virus replicon.
    Guo JT; Bichko VV; Seeger C
    J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection.
    Watanabe T; Sakamoto N; Nakagawa M; Kakinuma S; Itsui Y; Nishimura-Sakurai Y; Ueyama M; Funaoka Y; Kitazume A; Nitta S; Kiyohashi K; Murakawa M; Azuma S; Tsuchiya K; Oooka S; Watanabe M
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2537-45. PubMed ID: 21444704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
    Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
    Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.
    Broering R; Zhang X; Kottilil S; Trippler M; Jiang M; Lu M; Gerken G; Schlaak JF
    Gut; 2010 Aug; 59(8):1111-9. PubMed ID: 20639253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
    Jia YT; Wei L; Jiang D; Cong X; Fei R
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.